Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 03-2020 | 03-2018 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18 | 18 | 18 | N/A | N/A |
| Receivables | 1 | 1 | 1 | N/A | N/A |
| Inventories | 21 | 21 | 21 | N/A | N/A |
| TOTAL | $40 | $40 | $40 | $N/A | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $40 | $40 | $40 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 871 | 0 | 0 | 0 | 0 |
| TOTAL | $871 | $871 | $871 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $871 | $871 | $871 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -4,628 | -4,628 | -4,628 | N/A | N/A |
| Other shareholders' equity | 3,796 | 3,796 | 3,796 | 0 | 0 |
| TOTAL | $-832 | $-832 | $-832 | $N/A | $N/A |
| Total Liabilities And Equity | $40 | $40 | $40 | $0 | $0 |